CST967
CST967 (Compound 17) is a USP7 PROTAC degrader, and increasing the PROTAC concentration can enhance the degradation rate of USP7. CST967 can be used in cancer research[1].
Product Specifications
UNSPSC
12352005
Target
PROTACs
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cst967.html
Purity
99.33
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N(C1CCC(NC1=O)=O)C2=O)C(C2=C3)=CC=C3N4CCC(C(N5CCC(CCC(NC6=CC=C7C(N=CN(CC8(O)CCN(C(C[C@@H](C)C9=CC=CC=C9)=O)CC8)C7=O)=C6)=O)CC5)=O)CC4
Molecular Formula
C51H58N8O9
Molecular Weight
927.05
References & Citations
[1]Murgai, et al. "Targeting the deubiquitinase USP7 for degradation with PROTACs." Chemical Communications 58.63 (2022) : 8858-8861.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042980-100 1x 100 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/2980R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
